Daniel Swisher
Chairman chez CERUS CORPORATION
Fortune : 7 M $ au 31/03/2024
Profil
M. Daniel N. Swisher est président et chef de l'exploitation de Jazz Pharmaceuticals Plc, président et chef de l'exploitation de Jazz Pharmaceuticals, Inc. et administrateur indépendant de Corcept Therapeutics, Inc. et président de Cerus Corp. Il est membre du conseil d'administration de Corcept Therapeutics, Inc. M. Swisher était auparavant employé comme président, PDG, secrétaire et directeur par Sunesis Pharmaceuticals, Inc. et comme premier vice-président des ventes et du marketing par ALZA Corp. Il a obtenu son diplôme de premier cycle à l'université de Yale et un MBA à la Stanford Graduate School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/05/2023 | 55 014 ( 0,09% ) | 7 M $ | 31/03/2024 | |
CERUS CORPORATION
0,06% | 07/06/2023 | 104 545 ( 0,06% ) | 197 590 $ | 31/03/2024 |
| 26/10/2023 | 0 ( -.--% ) | - $ | 31/03/2024 | |
| 01/04/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Daniel Swisher
| Sociétés | Poste | Début |
|---|---|---|
| CERUS CORPORATION | Chairman | 01/10/2013 |
| CORCEPT THERAPEUTICS INCORPORATED | Director/Board Member | 18/06/2015 |
| PROTAGONIST THERAPEUTICS, INC. | Director/Board Member | 26/10/2023 |
Anciens postes connus de Daniel Swisher
| Sociétés | Poste | Fin |
|---|---|---|
| JAZZ PHARMACEUTICALS PLC | President | 01/10/2023 |
| VIRACTA THERAPEUTICS, INC. | Chief Executive Officer | 31/12/2017 |
| ALZA CORPORATION | Sales & Marketing | 01/09/2001 |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | President | - |
Formation de Daniel Swisher
| Yale University | Undergraduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| CERUS CORPORATION | Health Technology |
| CORCEPT THERAPEUTICS INCORPORATED | Health Technology |
| PROTAGONIST THERAPEUTICS, INC. | Health Technology |
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| Entreprise privées | 3 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. | Health Technology |
